Cagrilintide is an investigational long-acting amylin analog and is not approved by the FDA, EMA, or any comparable regulator for the treatment, cure, or prevention of obesity, type 2 diabetes, gastrointestinal disorders, or any other condition
Medicare usually covers Ozempic as a prescription treatment to help manage blood sugar levels in people with type 2 diabetes and for other FDA-approved indications
Read more or book a free consultation: Rx is up to clinical eligibility and a medical provider's discretion
If you are already experiencing significant GI symptoms, adding an antibioticwhich may also cause gastrointestinal upsetcould compound these effects and impact your ability to maintain adequate hydration and nutrition
This product is generally well-tolerated, but some users may experience nausea, fullness, bloating, mild stomach discomfort, or changes in bowel habits common with all GLP-1 therapies
Those seeking cellular level detox support